Friday, February 6, 2009

 

Atryn


http://karomy.mine.nu/vodypil/
atryn

An FDA advisory committee today recommended the approval of Atryn, which may become the first approved drug made from genetically engineered animals.
ATryn (antithrombin alfa) is a new drug in development for patients with antithrombin deficiency. ATryn information includes news, clinical trial results and side effects.
GTC Biotherapeutics (GTC, NASDAQ: GTCB) and OVATION Pharmaceuticals, Inc. announced that the Blood Products Advisory Committee of the U.S. Food and Drug Administration (FDA) voted
Shares of GTC Therapeutics were shooting up this morning after the company announced it had inked a $257 million licensing deal with Ovation Pharmaceuticals for its blood clotting
Prescription Drug Made From Milk of Genetically Engineered Goats.
ATryn® - RECOMBINANT HUMAN ANTITHROMBIN. GTC's lead product, ATryn®, a recombinant form of human antithrombin, also known as ATIII, is at the forefront of transgenic technology
First drug from transgenic goats nears approval ATryn, on Old MacDonald's Pharm First drug from transgenic goats nears approval
ATryn® MARKET AUTHORIZATION TRANSFERRED TO LEO PHARMA A/S FRAMINGHAM, MA - January 3, 2007 -- GTC Biotherapeutics, Inc. ("GTC", Nasdaq: GTCB) announced today that the market
EUROPEAN COMMISSION APPROVES ATryn® FRAMINGHAM, MA - August 2, 2006 -- GTC Biotherapeutics, Inc. ("GTC", Nasdaq: GTCB) reported today that the European Commission has granted
26-11-2007 LEO Pharma launches a new, safe drug, ATryn®, for preventing blood clots in patients. It concerns patients who, due to a genetic defect, cannot produce enough of the
Learn more about how the new drug Atryn is made from genetically engineered goats and how it can help people at risk for blood clots.

Stephanie kramer

Comments:

Post a Comment





<< Home

This page is powered by Blogger. Isn't yours?

Subscribe to Posts [Atom]